These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24316393)

  • 21. Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow.
    Barutcu I; Sezgin AT; Sezgin N; Gullu H; Esen AM; Topal E; Ozdemir R; Kosar F; Cehreli S
    Angiology; 2007; 58(4):401-7. PubMed ID: 17652225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloperoxidase is not associated with scintigraphic myocardial perfusion abnormalities in type 2 diabetic patients with mild stable anginal complaints.
    Wiersma JJ; Verberne HJ; Meuwese MC; Stroes ES; van Miert JN; van Eck-Smit BL; Tijssen JG; Piek JJ; Trip MD
    Clin Chim Acta; 2011 Jan; 412(1-2):86-90. PubMed ID: 20869358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inverse correlation between coronary blood flow velocity and sICAM-1 level observed in ischemic heart disease patients.
    Bencze J; Kiss RG; Toth-Zsamboki E; Vargova K; Kerecsen G; Korda A; Molnar F; Preda I
    Atherosclerosis; 2006 Sep; 188(1):142-9. PubMed ID: 16297392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow.
    Yucel H; Ozaydin M; Dogan A; Erdogan D; Turker Y; Ceyhan BM; Sutcu R
    Scand J Clin Lab Invest; 2012 Oct; 72(6):495-500. PubMed ID: 22950626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
    Aminian A; Boudjeltia KZ; Babar S; Van Antwerpen P; Lefebvre P; Crasset V; Leone A; Ducobu J; Friart A; Vanhaeverbeek M
    Eur J Intern Med; 2009 Sep; 20(5):527-32. PubMed ID: 19712859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of inflammatory biomarkers and long-term clinical outcomes in older adults with non-ST elevation acute coronary syndrome.
    Dirjayanto VJ; Martin-Ruiz C; Pompei G; Rubino F; Kunadian V
    Int J Cardiol; 2024 Aug; 409():132177. PubMed ID: 38761976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory response to mental stress and mental stress induced myocardial ischemia.
    Hammadah M; Sullivan S; Pearce B; Al Mheid I; Wilmot K; Ramadan R; Tahhan AS; O'Neal WT; Obideen M; Alkhoder A; Abdelhadi N; Mohamed Kelli H; Ghafeer MM; Pimple P; Sandesara P; Shah AJ; Hosny KM; Ward L; Ko YA; Sun YV; Weng L; Kutner M; Bremner JD; Sheps DS; Esteves F; Raggi P; Vaccarino V; Quyyumi AA
    Brain Behav Immun; 2018 Feb; 68():90-97. PubMed ID: 28986223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical analysis of the risk factors of slow coronary flow.
    Xia S; Deng SB; Wang Y; Xiao J; Du JL; Zhang Y; Wang XC; Li YQ; Zhao R; He L; Xiang YL; She Q
    Heart Vessels; 2011 Sep; 26(5):480-6. PubMed ID: 21207039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased plasma concentrations of adiponectin in patients with slow coronary flow.
    Selcuk H; Selcuk MT; Temizhan A; Maden O; Saydam GS; Ulupinar H; Dogan M; Aydin C; Topcu DI; Sasmaz A
    Heart Vessels; 2009 Jan; 24(1):1-7. PubMed ID: 19165561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pentraxin3 and high-sensitive C-reactive protein are independent inflammatory markers released during high-intensity exercise.
    Nakajima T; Kurano M; Hasegawa T; Takano H; Iida H; Yasuda T; Fukuda T; Madarame H; Uno K; Meguro K; Shiga T; Sagara M; Nagata T; Maemura K; Hirata Y; Yamasoba T; Nagai R
    Eur J Appl Physiol; 2010 Nov; 110(5):905-13. PubMed ID: 20640440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the relationship between myocardial perfusion imaging and coronary artery disease risk factors and markers of inflammation?
    Fleming RM; Harrington GM
    Angiology; 2008; 59(1):16-25. PubMed ID: 18319218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary slow flow phenomenon associated with high serum levels of soluble CD40 ligand and urotensin II: a multi-marker approach.
    Demir B; Caglar IM; Tureli HO; Pirhan O; Aciksari G; Serkan Çifçi ; Cem Özde ; Gedikbasi A; Zorkun C; Demir E; Karakaya O
    Clin Lab; 2014; 60(11):1909-20. PubMed ID: 25648034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
    Piechota W; Piechota W
    Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion.
    Baldus S; Heitzer T; Eiserich JP; Lau D; Mollnau H; Ortak M; Petri S; Goldmann B; Duchstein HJ; Berger J; Helmchen U; Freeman BA; Meinertz T; Münzel T
    Free Radic Biol Med; 2004 Sep; 37(6):902-11. PubMed ID: 15304260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers.
    Giansante C; Fiotti N; Di Chiara A; Altamura N; Wasserman S; Fioretti P; Guarnieri G
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):602-7. PubMed ID: 17667031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study.
    Durakoğlugil ME; Kocaman SA; Çetin M; Kirbaş A; Canga A; Erdoğan T; Çiçek Y
    Anadolu Kardiyol Derg; 2013 Feb; 13(1):39-44. PubMed ID: 23070634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome.
    Cavusoglu E; Ruwende C; Eng C; Chopra V; Yanamadala S; Clark LT; Pinsky DJ; Marmur JD
    Am J Cardiol; 2007 May; 99(10):1364-8. PubMed ID: 17493461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the relationship between coronary flow rates and myocardial perfusion abnormality in patients with nonobstructive coronary artery disease: an observational study in cardiac syndrome X and coronary slow flow.
    Özde C; Aktüre G; Aytekin S; Sayin AE; Ay EK; Coçkun G; Kaya A; Kayapinar O
    Nucl Med Commun; 2019 Nov; 40(11):1122-1129. PubMed ID: 31568270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial perfusion in patients undergoing primary angioplasty.
    Oduncu V; Tanalp AC; Erkol A; Sırma D; Dündar C; Akgün T; Türkyilmaz E; Kılıçgedik A; Gözübüyük G; Tigen K; Izgi A; Kirma C
    Am J Cardiol; 2011 Jan; 107(2):179-85. PubMed ID: 21129710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina.
    Li JJ; Zhang YP; Yang P; Zeng HS; Qian XW; Zhang CY; Zhu CG; Li J; Nan JL
    Coron Artery Dis; 2008 Aug; 19(5):293-7. PubMed ID: 18607165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.